LeMaitre Vascular Inc (NASDAQ: LMAT). Important positive changes in fundamentals have recently occurred: the consensus estimate for December, 2025 increased significantly, the consensus estimate for December, 2024 increased significantly, and significant quarterly earnings acceleration occurred.
Significant positive changes in investment behavior have recently occurred for LeMaitre Vascular Inc (NASDAQ: LMAT): positive upside/downside volume developed.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
LMAT’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a Value Builder.
LeMaitre Vascular has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. LeMaitre Vascular has a very low Appreciation Score of 14 but a good Power Rating of 78, and the Low Neutral Value Trend Rating results.
Recent Price Action
LeMaitre Vascular Inc (NASDAQ: LMAT) stock closed at $79.05 on 6/13/24 after a slight gain of 0.1%. Trading volume in this advance was normal. The stock has declined -1.7% during the last week but has been exceptionally strong relative to the market over the last nine months.
Be the first to comment